The standard contains eight quality statements that describe the health care you should receive to support the correct use of psychotropic medicines. This fact sheet explains each quality statement and what it means for you.  

This issue includes items on suicide prevention, innovation, patient experience, brain injury, primary care, virtual care, sepsis, delirium, and more. Along with the latest from Australian Health Review, Health Affairs, BMJ Quality & Safety, International Journal for Quality in Health Care and the UK’s NICE and the USA’s...

This issue includes items on maternity care, mental health, partnering with consumers, patient-reported measures (PROMs and PREMs), adverse events, digital health and more.  Along with the latest from BMJ Quality & Safety and the International Journal for Quality in Health Care. Also included is the latest from the USA’s Agency...

The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains eight quality statements and seven indicators to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment and uphold their rights, dignity, health and quality of life.

This resource lists the eight quality statements in the clinical care standard that aim to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.

This guide provides practical strategies to help digital mental health service providers effectively partner with service users in the governance, planning, design, measurement and evaluation of the service.